{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:18:46Z","timestamp":1769195926938,"version":"3.49.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1093\/chromsci\/bmy040","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T02:40:29Z","timestamp":1523587229000},"page":"687-694","source":"Crossref","is-referenced-by-count":10,"title":["LC\u2013MS-MS Determination of Oxcarbazepine and an Active Metabolite in Human Plasma for Clinical Application"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-951X","authenticated-orcid":false,"given":"Yuji","family":"Mano","sequence":"first","affiliation":[{"name":"Drug Metabolism and Pharmacokinetics, Biopharmaceutical Assessment Core Function Unit, Eisai Co., Ltd, 1-3, 5-Chome, Tokodai, Tsukuba-shi, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"key\n\t\t\t\t2018121711341621200_bmy040C1","first-page":"680","article-title":"Oxcarbazepine, an antiepileptic agent","volume":"23","author":"Kalis","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C2","first-page":"185","article-title":"Overview of the clinical pharmacokinetics of oxcarbazepine","volume":"24","author":"Flesch","year":"2004","journal-title":"Clinical Drug Investigation"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C3","first-page":"1023","article-title":"Clinical pharmacokinetics of oxcarbazepine","volume":"42","author":"May","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C4","first-page":"547","article-title":"Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects","volume":"66","author":"Volosov","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C5","first-page":"897","article-title":"Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS\/MS: application in a pharmacokinetic study","volume":"25","author":"Antunes","year":"2013","journal-title":"Chirality"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C6","first-page":"751","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry method for quantification of oxcarbazepine and its metabolite in human plasma","volume":"25","author":"Bhatt","year":"2011","journal-title":"Biomedical Chromatography"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C7","first-page":"517","article-title":"LC determination of oxcarbazepine and its active metabolite in human serum","volume":"28","author":"Levert","year":"2002","journal-title":"Journal of Pharmaceutical Biomedical Analysis"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C8","first-page":"304","article-title":"Simultaneous quantitative analysis of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine in human plasma by liquid chromatography-electrospray tandem mass spectrometry","volume":"45","author":"Sousa Maia","year":"2007","journal-title":"Journal of Pharmaceutical Biomedical Analysis"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C9","first-page":"20","article-title":"Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine","volume":"971","author":"Ferreira","year":"2014","journal-title":"Journal of Chromatography B"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C10","first-page":"153","article-title":"Development and validation of a LC\/MS\/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum","volume":"860","author":"Paglia","year":"2007","journal-title":"Journal of Chromatography B"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C11","first-page":"167","article-title":"Automated microanalysis of oxcarbazepine and its monohydroxy and transdiol metabolites in plasma by liquid chromatography","volume":"658","author":"Rouan","year":"1994","journal-title":"Journal of Chromatography B"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C12","first-page":"783","article-title":"The use of separation techniques in the analysis of some antiepileptic drugs: a critical review","volume":"39","author":"Mohamed","year":"2016","journal-title":"Journal of Liquid Chromatography & Related Technologies"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C13","first-page":"375","article-title":"Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience","volume":"7","author":"Bourgeois","year":"2005","journal-title":"Epilepsy Behavior"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C14","author":"European Medicines Agency","year":"2011"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C15","author":"US Food and Drug Administration","year":"2001"},{"key":"key\n\t\t\t\t2018121711341621200_bmy040C16","first-page":"195","article-title":"Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers","volume":"72","author":"Antunes","year":"2016","journal-title":"European Journal of Clinical Pharmacology"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/56\/8\/687\/27177835\/bmy040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T15:13:07Z","timestamp":1545059587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/56\/8\/687\/4992686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,5,4]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmy040","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,5,4]]}}}